Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Mar. 31, 2014 | 5-May-14 | |
Entity Information [Line Items] | ' | ' |
Entity Registrant Name | 'American Caresource Holdings, Inc. | ' |
Entity Central Index Key | '0001316645 | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Document Type | '10-Q | ' |
Document Period End Date | 31-Mar-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q1 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock, Shares Outstanding | ' | 6,713,960 |
Consolidated_Statements_of_Ope
Consolidated Statements of Operations (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Net revenues | $5,008 | $7,605 |
Cost of revenues | ' | ' |
Provider payments | 3,753 | 5,816 |
Administrative fees | 220 | 330 |
Claims administration and provider development | 971 | 889 |
Total cost of revenues | 4,944 | 7,035 |
Contribution margin | 64 | 570 |
Selling, general and administrative expenses | 1,324 | 1,503 |
Depreciation and amortization | 178 | 211 |
Total operating expenses | 1,502 | 1,714 |
Loss before income taxes | -1,438 | -1,144 |
Income tax provision | -3 | 7 |
Net loss | ($1,435) | ($1,151) |
Loss per basic and diluted common share | ($0.25) | ($0.20) |
Basic and diluted weighted average common shares outstanding | 5,729 | 5,711 |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $5,103 | $6,207 |
Accounts receivable, net | 1,648 | 1,977 |
Prepaid expenses and other current assets | 406 | 357 |
Deferred income taxes | 6 | 6 |
Total current assets | 7,163 | 8,547 |
Property and equipment, net | 1,201 | 1,236 |
Other assets: | ' | ' |
Deferred income taxes | 215 | 215 |
Other non-current assets | 391 | 391 |
Intangible assets, net | 608 | 640 |
Total assets | 9,578 | 11,029 |
Current liabilities: | ' | ' |
Due to service providers | 1,580 | 1,865 |
Accounts payable and accrued liabilities | 1,251 | 1,056 |
Total current liabilities | 2,831 | 2,921 |
Commitments and contingencies | ' | ' |
Shareholders' equity: | ' | ' |
Preferred stock, $0.01 par value; 10,000 shares authorized, none issued | 0 | 0 |
Common stock, $0.01 par value; 40,000 shares authorized; 5,713 shares issued and outstanding in 2014 and 2013. | 57 | 57 |
Additional paid-in capital | 23,223 | 23,149 |
Accumulated deficit | -16,533 | -15,098 |
Total stockholders' equity | 6,747 | 8,108 |
Total liabilities and stockholders' equity | $9,578 | $11,029 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, except Per Share data, unless otherwise specified | ||
Shareholders' equity: | ' | ' |
Preferred stock, par value (in dollars per share) | $0.01 | $0.01 |
Preferred stock, shares authorized | 10,000 | 10,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, shares authorized | 40,000 | 40,000 |
Common stock, shares issued | 5,713 | 5,713 |
Common Stock, shares outstanding | 5,713 | 5,713 |
Consolidated_Statement_of_Stoc
Consolidated Statement of Stockholders' Equity (USD $) | Total | Common Stock | Additional Paid-in Capital | Accumulated Deficit |
In Thousands, unless otherwise specified | ||||
Balance at Dec. 31, 2013 | $8,108 | $57 | $23,149 | ($15,098) |
Balance, shares at Dec. 31, 2013 | 5,713 | 5,713 | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' |
Net loss | -1,435 | 0 | 0 | -1,435 |
Stock-based compensation expense | 74 | 0 | 74 | 0 |
Balance at Mar. 31, 2014 | $6,747 | $57 | $23,223 | ($16,533) |
Balance, shares at Mar. 31, 2014 | 5,713 | 5,713 | ' | ' |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Cash flows from operating activities: | ' | ' |
Net loss | ($1,435) | ($1,151) |
Adjustments to reconcile net loss to net cash used in operations: | ' | ' |
Non-cash stock-based compensation expense | 74 | 77 |
Depreciation and amortization | 178 | 211 |
Deferred income taxes | 0 | 1 |
Changes in operating assets and liabilities: | ' | ' |
Accounts receivable | 329 | -372 |
Prepaid expenses and other assets | -49 | -4 |
Accounts payable and accrued liabilities | 195 | -27 |
Due to service providers | -285 | -427 |
Net cash used in operating activities | -993 | -1,692 |
Cash flows from investing activities: | ' | ' |
Investment in software development costs | -99 | -154 |
Additions to property and equipment | -12 | -9 |
Net cash used in investing activities | -111 | -163 |
Net decrease in cash and cash equivalents | -1,104 | -1,855 |
Cash and cash equivalents at beginning of period | 6,207 | 10,705 |
Cash and cash equivalents at end of period | 5,103 | 8,850 |
Supplemental cash flow information: | ' | ' |
Cash paid for taxes, net of refunds | $10 | $13 |
Description_of_Business_and_Ba
Description of Business and Basis of Presentation | 3 Months Ended | |
Mar. 31, 2014 | ||
Description of Business and Basis of Presentation [Abstract] | ' | |
Description of Business and Basis of Presentation | ' | |
Description of Business and Basis of Presentation | ||
American CareSource Holdings, Inc. ("ACS,” "the Company,” the “Registrant,” “we,” “us,” or “our”) works to help its clients control healthcare costs by offering cost containment strategies, primarily through the utilization of a comprehensive national network of ancillary healthcare service providers. The Company markets its services to a number of healthcare companies including third party administrators (“TPAs”), insurance companies, large self-funded organizations, various employer groups and preferred provider organizations ("PPOs"). The Company offers payors this solution by: | ||
• | lowering its payors’ ancillary care costs through its network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own; | |
• | providing payors with a comprehensive network of ancillary healthcare service providers that is tailored to each payor’s specific needs and is available to each payor’s members for covered services; | |
• | providing payors with claims management, reporting, processing and payment services; | |
• | performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor-specific provider networks; and | |
• | credentialing network service providers for inclusion in the payor-specific provider networks. | |
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), interim reporting requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the rules and regulations of the Securities and Exchange Commission (“SEC”). Consequently, financial information and disclosures normally included in financial statements prepared annually in accordance with GAAP have been condensed or omitted. Balance sheet amounts are as of March 31, 2014 and December 31, 2013 and operating results are for the three months ended March 31, 2014 and 2013, and include all normal and recurring adjustments we consider necessary for the fair, summarized presentation of our financial position and operating results. Certain prior year amounts have been reclassified within the consolidated statement of operations to conform to the current year presentation. As these are condensed financial statements, readers of this report should, therefore, refer to the consolidated financial statements and the notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, filed with the SEC on February 28, 2014. | ||
The Company uses the “management approach” for reporting information about segments in annual and interim financial statements. The management approach is based on the way the chief operating decision-maker organizes segments within a company for making operating decisions and assessing performance. Reportable segments are based on products and services, geography, legal structure, management structure and any other manner in which management disaggregates a company. Based on the “management approach” model, the Company has determined that its business is comprised of a single operating segment. | ||
Our interim results of operations are not necessarily indicative of results of operations that will be realized for the full fiscal year. |
Revenue_Recognition
Revenue Recognition | 3 Months Ended | |||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||
Revenue Recognition [Abstract] | ' | |||||||||||||||||||||
Revenue Recognition | ' | |||||||||||||||||||||
Revenue Recognition | ||||||||||||||||||||||
The Company recognizes revenue on the services that it provides, which includes (i) providing payor clients with a comprehensive network of ancillary healthcare providers, (ii) providing claims management, reporting, processing and payment services, (iii) providing network/need analysis to assess the benefits to payor clients of adding additional/different service providers to the client-specific provider networks and (iv) providing credentialing of network service providers for inclusion in the client payor-specific provider networks. Revenue is recognized when services are delivered, which occurs after processed claims are billed to the client payors and collections are reasonably assured. The Company estimates revenues and costs of revenues using average historical collection rates and average historical margins earned on claims. Periodically, revenues are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected. | ||||||||||||||||||||||
The Company determines whether it is acting as a principal or agent in the fulfillment of the services rendered. After careful evaluation of the key gross and net revenue recognition indicators, the Company acknowledges that while the determination of gross versus net reporting is highly judgmental in nature, the Company has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting. | ||||||||||||||||||||||
Following are the key indicators that support the Company’s conclusion that it acts as a principal when settling claims for service providers through its contracted service provider network: | ||||||||||||||||||||||
• | The Company is the primary obligor in the arrangement. The Company has assessed its role as primary obligor as a strong indicator of gross reporting. The Company believes that it is the primary obligor in its transactions because it is responsible for providing the services desired by its client payors. The Company has distinct, separately negotiated contractual relationships with its client payors and with the ancillary healthcare providers in its networks. The Company does not negotiate “on behalf of” its client payors and does not hold itself out as the agent of the client payors when negotiating the terms of the Company’s ancillary healthcare service provider agreements. The Company’s agreements contractually prohibit client payors and service providers to enter into direct contractual relationships with one another. The client payors have no control over the terms of the Company’s agreements with the service providers. In executing transactions, the Company assumes key performance-related risks. The client payors hold the Company responsible for fulfillment, as the provider, of all of the services the client payors are entitled to under their contracts; client payors do not look to the service providers for fulfillment. In addition, the Company bears the pricing/margin risk as the principal in the transactions. Because the contracts with the client payors and service providers are separately negotiated, the Company has complete discretion in negotiating both the prices it charges its client payors and the financial terms of its agreements with the service providers. Since the Company’s profit is the spread between the amounts received from the client payors and the amount paid to the service providers, it bears significant pricing/margin risk. There is no guaranteed mark-up payable to the Company on the amount the Company has contracted. Thus, the Company bears the risk that amounts paid to the service provider will be greater than the amounts received from the client payors, resulting in a loss or negative claim. | |||||||||||||||||||||
• | The Company has latitude in establishing pricing. As stated above, the Company has complete latitude in negotiating the price to be paid to the Company by each client payor and the price to be paid to each contracted service provider. This type of pricing latitude indicates that the Company has the risks and rewards normally attributed to a principal in the transactions. | |||||||||||||||||||||
• | The Company changes the product or performs part of the services. The Company provides the benefits associated with the relationships it builds with the client payors and the service providers. While the parties could deal with each other directly, the client payors would not have the benefit of the Company’s experience and expertise in assembling a comprehensive network of service providers, in claims management, reporting and processing and payment services, in performing network/needs analysis to assess the benefits to client payors of adding additional/different service providers to the client payor-specific provider networks, and in credentialing network service providers. | |||||||||||||||||||||
• | The Company has complete discretion in supplier selection. One of the key factors considered by client payors who engage the Company is to have the Company undertake the responsibility for identifying, qualifying, contracting with and managing the relationships with the ancillary healthcare service providers. As part of the contractual arrangement between the Company and its client payors, the payors identify their obligations to their respective covered persons and then work with the Company to determine the types of ancillary healthcare services required in order for the payors to meet their obligations. The Company may select the providers and contract with them to provide services at its discretion. | |||||||||||||||||||||
• | The Company is involved in the determination of product or service specifications. The Company works with its client payors to determine the types of ancillary healthcare services required in order for the payors to meet their obligations to their respective covered persons. In some respects, the Company is customizing the product through its efforts and ability to assemble a comprehensive network of providers for its payors that is tailored to each payor’s specific needs. In addition, as part of its claims processing and payment services, the Company works with the client payors, on the one hand, and the providers, on the other, to set claims review, management and payment specifications. | |||||||||||||||||||||
• | The supplier (and not the Company) has credit risk. The Company believes it has some level of credit risk, but that risk is mitigated because the Company does not remit payment to providers unless and until it has received payment from the relevant client payors following the Company’s processing of a claim. | |||||||||||||||||||||
• | The amount that the Company earns is not fixed. The Company does not earn a fixed amount per transaction nor does it realize a per-person per-month charge for its services. | |||||||||||||||||||||
The Company has evaluated the other indicators of gross and net revenue recognition, including whether or not the Company has general inventory risk. The Company does not have any general inventory risk, as its business is not related to the manufacture, purchase or delivery of goods and it does not purchase in advance any of the services to be provided by the ancillary healthcare service providers. While the absence of this risk would be one indicator in support of net revenue reporting, as described in detail above, the Company has carefully evaluated all of the key gross and net revenue recognition indicators and has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting. | ||||||||||||||||||||||
If the Company were to report its revenues net of provider payments rather than on a gross reporting basis, for the three months ended March 31, 2014, its net revenues would have been approximately $1.3 million. For the three months ended March 31, 2013, its net revenues would have been approximately $1.8 million. | ||||||||||||||||||||||
The Company records a provision for refunds based on an estimate of historical refund amounts. Refunds are paid to payors for overpayments on claims, claims paid in error, and claims paid for non-covered services. In some instances, we will recoup payments made to the ancillary service provider if the claim has been fully resolved. The evaluation is performed periodically and is based on historical data. We present revenue net of the provision for refunds on the consolidated statement of operations. | ||||||||||||||||||||||
During the three months ended March 31, 2014 and 2013, three of the Company’s clients comprised a significant portion of the Company’s revenues. The following is a summary of the approximate amounts of the Company’s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands): | ||||||||||||||||||||||
As of March 31, 2014 | Three months ended March 31, 2014 | As of March 31, 2013 | Three months ended | |||||||||||||||||||
March 31, 2013 | ||||||||||||||||||||||
Accounts Receivable | Net Revenue | % of Total Revenue | Accounts Receivable | Net Revenue | % of Total Revenue | |||||||||||||||||
Material Client Relationship | $ | 774 | $ | 1,232 | 24.6 | % | $ | 951 | $ | 2,357 | 31 | % | ||||||||||
HealthSCOPE Benefits, Inc. | 128 | 694 | 13.9 | 101 | 583 | 7.7 | ||||||||||||||||
HealthMarkets, Inc. | 167 | 499 | 10 | 188 | 657 | 8.6 | ||||||||||||||||
All Others | 1,042 | 2,636 | 52.6 | 1,754 | 4,049 | 53.2 | ||||||||||||||||
Allowance for Uncollectable Receivables/Provision for refunds | (463 | ) | (53 | ) | (1.1 | ) | (190 | ) | (41 | ) | (0.5 | ) | ||||||||||
$ | 1,648 | $ | 5,008 | 100 | % | $ | 2,804 | $ | 7,605 | 100 | % | |||||||||||
Earnings_Loss_Per_Share
Earnings (Loss) Per Share | 3 Months Ended |
Mar. 31, 2014 | |
Earnings Per Share [Abstract] | ' |
Earnings (Loss) Per Share | ' |
Earnings (Loss) Per Share | |
For purposes of this calculation, outstanding stock options, stock warrants, and unvested restricted stock units are considered common stock equivalents using the treasury stock method, and are the only such equivalents outstanding. For all periods presented all equivalent units outstanding were anti-dilutive. As of March 31, 2014, options to purchase approximately 857,000 shares of common stock, warrants to purchase 44,400 shares of common stock and approximately 29,800 unvested restricted stock units were excluded from the calculation as their impact would be anti-dilutive. |
Software_Development_Costs
Software Development Costs | 3 Months Ended |
Mar. 31, 2014 | |
Software Development Costs [Abstract] | ' |
Software Development Costs | ' |
Software Development Costs | |
The Company capitalizes costs associated with internally developed software, developed for internal use only, during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. Costs of significant upgrades and enhancements that result in additional functionality also are capitalized, whereas costs incurred for maintenance and minor upgrades and enhancements are expensed as incurred. Capitalized costs include external direct costs of materials and services utilized in developing or obtaining internal-use software and payroll and payroll-related expenses for employees who are directly associated with and devote time to the internal-use software projects. Capitalization of such costs begins when the preliminary project stage is complete and ceases no later than the point at which the project is substantially complete and ready for its intended purpose. Capitalized costs are amortized using the straight-line method over the useful life of the software, which is typically five years. | |
During the three months ended March 31, 2014, the Company capitalized approximately $99,000. During the three months ended March 31, 2013, the Company capitalized approximately $154,000. |
Severance_Charges
Severance Charges | 3 Months Ended |
Mar. 31, 2014 | |
Restructuring and Related Activities [Abstract] | ' |
Severance Charges | ' |
Severance Charges | |
The Company recorded $108,000 in severance charges during the three months ended March 31, 2014. In an effort to conserve cash resources for the existing business and strategic opportunities, the Company reduced its headcount by six full-time employees. This expense is included in selling, general and administrative (“SG&A”) expenses as presented per the Consolidated Statement of Operations. |
Related_Party_Transactions_Not
Related Party Transactions (Notes) | 3 Months Ended |
Mar. 31, 2014 | |
Related Party Transactions [Abstract] | ' |
Related Party Transactions | ' |
Related Party Transactions | |
On January 10, 2014, the Company entered into an arrangement with Equity Dynamics, Inc. for monthly strategic consulting services. As part of the arrangement, Equity Dynamics, Inc. will receive a monthly fee of $10,000 for performance of such consulting services. Equity Dynamics, Inc. is a company owned by John Pappajohn and served by Executive Vice-President Matthew Kinley, both active members on the Board of Directors. | |
During the three months ended March 31, 2014, the Company incurred expenses of $30,000 for the consulting services described above payable to Equity Dynamics, Inc. This expense is included in selling, general and administrative (“SG&A”) expenses as presented per the Consolidated Statement of Operations. |
Subsequent_Events_Notes
Subsequent Events (Notes) | 3 Months Ended |
Mar. 31, 2014 | |
Subsequent Events [Abstract] | ' |
Subsequent Events | ' |
Subsequent Events | |
We evaluate events and transactions that occur after the balance sheet date as potential subsequent events. Subsequent to March 31, 2014, the Company announced its strategy to enter the Urgent Care market. In addition, the company also announced that its Board has named Dr. Richard W. Turner its Chief Executive Officer, in addition to his role as Chairman of the Board, to lead the organization into the Urgent Care market. | |
On April 28, 2014, American CareSource Holdings, Inc. (the “Company”) entered into an employment agreement with its Chairman of the Board, Richard W. Turner (the “Employment Agreement”), appointing him as Chief Executive Officer of the Company. | |
Under the terms of the Employment Agreement, the Company will employ Dr. Turner as the Company’s Chairman and Chief Executive Officer for an initial one-year term to commence on April 29, 2014, to be automatically renewed for successive one-year periods thereafter unless either party provides the other with 90 days' notice of non-renewal. | |
Dr. Turner will receive an annual base salary in the amount of $300,000 and will be eligible to participate in the Company’s bonus compensation plan pursuant to which he will be eligible for an annual performance bonus to be determined by the Board based on the Company’s performances, but in no event less than $50,000. In addition, Dr. Turner was granted an incentive stock option to purchase 350,000 shares of common stock and 50,000 shares of restricted common stock of the Company. | |
On April 30, 2014, the Company entered into a definitive agreement to acquire substantially all the assets of CorrectMed LLC of Atlanta, Ga., which includes urgent care centers in located in Locust Grove and Decatur, Georgia. The definitive agreement is subject to certain customary closing conditions. The purchase price of the assets was $2.7 million, which includes $2.2 million of cash payable at the closing of the transaction, and a $500,000 note payable due and payable on the first anniversary of the date of closing. Interest is payable on the note at 5%. The purchase price is subject to certain post-closing adjustments. | |
On May 5, 2014, American CareSource Holdings, Inc. (the “Company”) closed its private placement of 1,000,000 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), at a purchase price of $2.00 per share for an aggregate purchase price of $2,000,000 for the Shares. | |
The investors in the offering included John Pappajohn, Mark C. Oman and Matt Kinley, who are each directors of the Company, as well as certain other non-affiliated investors. |
Revenue_Recognition_Tables
Revenue Recognition (Tables) | 3 Months Ended | |||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||
Revenue Recognition [Abstract] | ' | |||||||||||||||||||||
Summary of Revenues and Accounts Receivable Contributed by Client | ' | |||||||||||||||||||||
The following is a summary of the approximate amounts of the Company’s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands): | ||||||||||||||||||||||
As of March 31, 2014 | Three months ended March 31, 2014 | As of March 31, 2013 | Three months ended | |||||||||||||||||||
March 31, 2013 | ||||||||||||||||||||||
Accounts Receivable | Net Revenue | % of Total Revenue | Accounts Receivable | Net Revenue | % of Total Revenue | |||||||||||||||||
Material Client Relationship | $ | 774 | $ | 1,232 | 24.6 | % | $ | 951 | $ | 2,357 | 31 | % | ||||||||||
HealthSCOPE Benefits, Inc. | 128 | 694 | 13.9 | 101 | 583 | 7.7 | ||||||||||||||||
HealthMarkets, Inc. | 167 | 499 | 10 | 188 | 657 | 8.6 | ||||||||||||||||
All Others | 1,042 | 2,636 | 52.6 | 1,754 | 4,049 | 53.2 | ||||||||||||||||
Allowance for Uncollectable Receivables/Provision for refunds | (463 | ) | (53 | ) | (1.1 | ) | (190 | ) | (41 | ) | (0.5 | ) | ||||||||||
$ | 1,648 | $ | 5,008 | 100 | % | $ | 2,804 | $ | 7,605 | 100 | % | |||||||||||
Revenue_Recognition_Net_Provid
Revenue Recognition (Net Provider Payments) (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Revenue Recognition [Abstract] | ' | ' |
Revenues, net of provider payments | $1.30 | $1.80 |
Revenue_Recognition_Revenue_an
Revenue Recognition (Revenue and Accounts Receivable) (Details) (USD $) | 3 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 |
Concentration Risk [Line Items] | ' | ' | ' |
Entity Wide Revenue Major Customer Number | 3 | ' | ' |
Allowance for Uncollectable Receivables | ($463) | ($190) | ' |
Accounts receivable, net | 1,648 | 2,804 | 1,977 |
Provision for refunds | -53 | -41 | ' |
Net revenues | 5,008 | 7,605 | ' |
Sales Revenue | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
% of Total Revenue | 100.00% | 100.00% | ' |
Sales Revenue | Provision for refunds | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
% of Total Revenue | -1.10% | -0.50% | ' |
Customer Concentration Risk | Material Client Relationship | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Accounts Receivable, Gross | 774 | 951 | ' |
Revenue, Gross | 1,232 | 2,357 | ' |
Customer Concentration Risk | HealthSCOPE Benefits, Inc. [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Accounts Receivable, Gross | 128 | 101 | ' |
Revenue, Gross | 694 | 583 | ' |
Customer Concentration Risk | HealthMarkets, Inc | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Accounts Receivable, Gross | 167 | 188 | ' |
Revenue, Gross | 499 | 657 | ' |
Customer Concentration Risk | All Others | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Accounts Receivable, Gross | 1,042 | 1,754 | ' |
Revenue, Gross | $2,636 | $4,049 | ' |
Customer Concentration Risk | Sales Revenue | Material Client Relationship | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
% of Total Revenue | 24.60% | 31.00% | ' |
Customer Concentration Risk | Sales Revenue | HealthSCOPE Benefits, Inc. [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
% of Total Revenue | 13.90% | 7.70% | ' |
Customer Concentration Risk | Sales Revenue | HealthMarkets, Inc | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
% of Total Revenue | 10.00% | 8.60% | ' |
Customer Concentration Risk | Sales Revenue | All Others | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
% of Total Revenue | 52.60% | 53.20% | ' |
Earnings_Loss_Per_Share_Detail
Earnings (Loss) Per Share (Details) | 3 Months Ended |
Mar. 31, 2014 | |
Stock options | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' |
Antidilutive shares excluded from calculation of earnings per share | 857,000 |
Stock warrants | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' |
Antidilutive shares excluded from calculation of earnings per share | 44,400 |
Restricted Stock Units (RSU's) | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' |
Antidilutive shares excluded from calculation of earnings per share | 29,800 |
Software_Development_Costs_Det
Software Development Costs (Details) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Software Development Costs [Abstract] | ' | ' |
Useful life of developed software | '5 years | ' |
Capitalized software development costs | $99 | $154 |
Severance_Charges_Details
Severance Charges (Details) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Mar. 31, 2014 |
Employees | |
Restructuring Cost and Reserve [Line Items] | ' |
Number of positions eliminated | 6 |
Selling, General and Administrative Expenses [Member] | Special Severance Benefits [Member] | ' |
Restructuring Cost and Reserve [Line Items] | ' |
Total severance charge | 108 |
Related_Party_Transactions_Det
Related Party Transactions (Details) (Equity Dynamics. Inc. [Member], Consulting Services [Member], USD $) | 3 Months Ended |
Mar. 31, 2014 | |
Related Party Transaction [Line Items] | ' |
Monthly fee for consulting services | $10,000 |
Selling, General and Administrative Expenses [Member] | ' |
Related Party Transaction [Line Items] | ' |
Related party, incurred expenses | $30,000 |
Subsequent_Events_Subsequent_E
Subsequent Events Subsequent Events (Details) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 | 5-May-14 | Apr. 30, 2014 | Apr. 30, 2014 | Apr. 29, 2014 | Apr. 29, 2014 |
Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | |||
CorrectMed LLC of Atlanta, GA [Member] | CorrectMed LLC of Atlanta, GA [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | ||||
Notes Payable [Member] | Restricted Stock [Member] | ||||||
Subsequent Event [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Annual base salary | ' | ' | ' | ' | ' | $300,000 | ' |
Minimum annual bonus under plan | ' | ' | ' | ' | ' | 50,000 | ' |
Options granted | ' | ' | ' | ' | ' | 350,000 | ' |
Restricted common stock shares granted | ' | ' | ' | ' | ' | ' | 50,000 |
Purchase price | ' | ' | ' | 2,700,000 | ' | ' | ' |
Cash consideration | ' | ' | ' | 2,200,000 | ' | ' | ' |
Note payable due to business combination | ' | ' | ' | 500,000 | ' | ' | ' |
Stated interest rate | ' | ' | ' | ' | 5.00% | ' | ' |
Private placement, shares issued | ' | ' | 1,000,000 | ' | ' | ' | ' |
Common stock, par value (in dollars per share) | $0.01 | $0.01 | $0.01 | ' | ' | ' | ' |
Share price (in dollars per share) | ' | ' | $2 | ' | ' | ' | ' |
Stock issued, value of shares | ' | ' | $2,000,000 | ' | ' | ' | ' |